|
Exclusive – Glaxo R&D boss says Advair safe from generics
Reuters UK L) $8 billion (5 billion pounds)-a-year Advair treatment for asthma and smoker's cough can hope to capture only "a very small fraction" of its sales, the British drugmaker's research chief said on Tuesday. Advair, which uses an inhaler to deliver two … |
View full post on asthma – Google News